About Mercator MedSystems
Mercator MedSystems is a Healthcare company based in San Leandro (United States) founded in 2000. Catheter-guided microfluid injection systems are developed for targeted tissue therapies. Mercator MedSystems has raised $31.8 million across 5 funding rounds from investors including HHS, Shenzhen Xinlitai Pharmaceutical and Volcano Capital Management. Mercator MedSystems offers products and services including Bullfrog Micro-Infusion Device. Its focus areas include Life Sciences, Drug Delivery, Intravenous and Genomics. Its legal entity is Mercator MedSystems, Inc. Its competitors include BridgeBio, Spark Therapeutics and Insulet; 3 of its 3 listed competitors have raised funding.
Company details
Mercator MedSystems was founded in 2000 and is based in San Leandro, United States. Micro-infusion catheters are developed by the company for non-systemic injection of therapeutic agents through blood vessel walls into deep tissues. These systems support applications in plaque stabilization for diseased vessels, anti-tumor drug delivery, growth factor administration for cell stimulation, and stem cell or gene therapies. Operations focus on vascular diseases, hypertension, oncology, and regenerative medicine sectors.
- Headquarters San Leandro, United States
- SectorsHealthcare
- Website mercatormed.com
- Social LinkedIn
- Legal Name Mercator Medsystems, Inc.
- Total Equity Funding$31.8M (USD)
in 5 rounds
- Latest Funding Round$14.3M (USD), Series D
Jun 2019
- InvestorsHHS
& 4 more
Products & Services of Mercator MedSystems
Mercator MedSystems offers a comprehensive portfolio of products and services, including Bullfrog Micro-Infusion Device.
Delivers drugs directly to vessel walls for targeted vascular treatments.
Funding Insights of Mercator MedSystems
Mercator MedSystems has successfully raised a total of $31.8M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $14.3 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.8M
- Total Rounds 5
- Last Round Series D — $14.3M
- First Round $218,055
(Sep 2009)
- Investors Count 5
All 5 funding rounds of Mercator MedSystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $14.3M | Series D | – | – | – |
| Jun 2018 | $11M | Series D | – | Shenzhen Xinlitai Pharmaceutical | – |
| Jun 2013 | $6.5M | Series B | – | – | |
| Sep 2011 | $1.35M | Grant | – | – | |
| Sep 2009 | $218,055 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Mercator MedSystems
Mercator MedSystems has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Shenzhen Xinlitai Pharmaceutical and Volcano Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| volcanocap.com | ||||
| crockercapital.com | ||||
Tech and life sciences focused VC firm investing in geographies such as the US | aphelioncapital.net | Mill Valley, United States | ||
Therapies for metabolism, cardiovascular, and oncology diseases are developed. | 1998 | salubris.com | Greenview, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Mercator MedSystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mercator MedSystems
2 people are tracked at Mercator MedSystems (2 in leadership).
| Name | Role | Group |
|---|---|---|
Kirk Seward | Founder, President And CEO | Leadership |
Steve Baker | Chief Financial Officer | Leadership |
Complete people profiles for Mercator MedSystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mercator MedSystems
3 dated milestones of Mercator MedSystems across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Mercator MedSystems is founded.
- Funding First funding round of $218K.
- Funding Latest funding round, Series D, of $14.3M.
Competitors of Mercator MedSystems
Mercator MedSystems has 3 listed competitors in our database, 3 of them funded. They include BridgeBio, Spark Therapeutics and Insulet.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| insulet.com | 2000 | Boston, United States | $120.4M | 2,600 | Wearable insulin infusion systems are developed for diabetes patients. |
Detailed competitors of Mercator MedSystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Mercator MedSystems
The website of Mercator MedSystems (mercatormed.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 120.2% vs previous month
Websites whose visitors overlap most with Mercator MedSystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
baxa.com | baxa.com | 100% | – | ||
| antarespharma.com | 100% | View details | |||
| trudellmed.com | 100% | 18.4K | #1,187,158 | View details | |
kurvetech.com | kurvetech.com | 100% | – | ||
medima.com.pl | medima.com.pl | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Mercator MedSystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Mercator MedSystems (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mercator Medsystems
Complete news archive for Mercator MedSystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mercator MedSystems
Mercator MedSystems was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Mercator MedSystems is headquartered in San Leandro, United States. It is registered at San Leandro, California, United States.
Mercator MedSystems is a funded company, having raised a total of $31.8M across 5 funding rounds to date. The company's 1st funding round was a Grant of $218.06K, raised on Sep 2009.
Mercator MedSystems was founded in 2000 and is based in San Leandro, United States. Micro-infusion catheters are developed by the company for non-systemic injection of therapeutic agents through blood vessel walls into deep tissues. These systems support applications in plaque stabilization for diseased vessels, anti-tumor drug delivery, growth factor administration for cell stimulation, and stem cell or gene therapies. Operations focus on vascular diseases, hypertension, oncology, and regenerative medicine sectors.
Mercator MedSystems's top competitors include Spark Therapeutics, BridgeBio and Insulet.
Mercator MedSystems offers Bullfrog Micro-Infusion Device.
Mercator MedSystems has 5 investors. Key investors include HHS, Shenzhen Xinlitai Pharmaceutical, Volcano Capital Management, Crocker Capital, and Aphelion Capital.
Mercator MedSystems operates through Mercator Medsystems, Inc..